3.5200
+0.0200
+(0.57%)
At close: January 17 at 5:06:30 PM GMT+1
Key Executives
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Karl Alexius Tiger Karlsson | Founder & Executive Chairman | 1.32M | -- | 1974 |
| Mr. Christoffer Tell | Chief Financial Officer | -- | -- | 1987 |
| Mr. Fredrik Hellqvist | Vice President of Sales & Marketing | 601.85k | -- | 1973 |
| Mr. Lars Minor | Chief Executive Officer | -- | -- | 1970 |
Newbury Pharmaceuticals AB (publ)
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 6
Description
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. The company offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.
Corporate Governance
Newbury Pharmaceuticals AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available